Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy

Written by Andreas Villaester on 14th February 2020. Posted in Client News.

• Previous
• Next